跳至主要内容
临床试验/JPRN-jRCTs031200436
JPRN-jRCTs031200436已完成2 期

A prospective multi-center open trial to evaluate the safety and efficacy of favipiravir and camostat mesilate in patients with COVID-19.

Yutaka Tokue0 个研究点目标入组 12 人开始时间: 2021年3月23日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

It was a registration of a small number of cases and did not lead to a statistical examination.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) SARS-CoV-2 test positive
  • 2) diagnosed with COVID-19
  • 3) fever above 37.5 degree Celsius, or pneumonia shadow on chest X-ray or CT-scan
  • 4) hospital admission
  • 6) patients who have given written consent to participate in the study

排除标准

  • 1) pregnancy
  • 2) lactation
  • 3) Women who are not able to give informed consent regarding contraception and using contraceptive divices from the initiation of favipiravir to 14 days after the end of its administration. Men or their partners who are not able to give informed consent regarding contraception and using contraceptive divices from the initiation of favipiravir to 10 days after the end of its administration.

研究者

发起方
Yutaka Tokue

相似试验